Grace Therapeutics Inc GRCE

$1.89 -0.06 (-3.08%)

Valuation

Market cap
41,020,000
Revenue TTM
$0
Net income TTM
$-7,790,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
168,600
Avg volume
130,718
Day's range
$1.85 – $2.03
Shares out
21,036,000
Stochastic %K
15%
Beta
0.33
Analysts
Strong Sell
Price target
$6.00

Price

Company profile

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a...

Show more

Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an injectable formulation developed to treat aneurysmal subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to enhance neurological symptoms of Ataxia-Telangiectasia (A-T); and GTX-101, a topical bio adhesive film-forming bupivacaine spray for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Industry
Biotechnology
Sector
Healthcare
Phone
609 322 1602
Website
https://www.gracetx.com
Address
103 Carnegie Center, Suite 300, Princeton, United States

Latest news

Stocktwits

whiteboytrippin Oct 15, 6:54 PM
$GRCE game on
0 replies
HarveySpecter20 Oct 13, 10:26 PM
$GRCE they added again: https://ir.stockpr.com/gracetx/sec-filings-email/content/0001493152-26-046899/ownership.html
1 replies
Evaluwait Oct 9, 4:10 PM
$GRCE Terrible volume. I was going to buy this morning but 7 cents spread. I don’t think we’ll see below $2 again. 🤞
1 replies
Carnut68 Oct 7, 6:24 PM
$GRCE Added more today. 65k shares now. Only a matter of time.
0 replies
HarveySpecter20 Oct 6, 10:04 AM
$GRCE opaleye seems to continue to accumulate shares. https://ir.stockpr.com/gracetx/sec-filings-email/content/0001493152-26-045809/ownership.html
0 replies
NVDAMillionaire Sep 22, 7:38 PM
$GRCE Great piece that accurately captures GRCE's current position. So if you want to refresh your understanding of GRCE or learn about GRCE for the first time, this is essential reading. https://everyticker.com/quote/GRCE/analysis/gtx-104-manufacturing-reset-why-grace-therapeutics-2-stock-reflects-execution-risk-not-clinical-failure-nasdaq-grce
2 replies
HarveySpecter20 Sep 19, 9:41 AM
$GRCE added more here.
0 replies
focafoca99 Sep 18, 8:20 PM
$GRCE held its annual stockholder meeting, electing five directors and approving advisory votes. https://www.rapidticker.com/news/grce-sec-filing-94462c
0 replies